Updated
OnKure TherapeuticsOKUR · Healthcare
$3.12-2.04%
Market cap$127M
IndustryBiotechnology
OnKure Therapeutics (OKUR) Superinvestor holders
4 of the superinvestors we track hold OnKure Therapeutics (OKUR) in their latest 13F filings, $5M in total.
Summary
The largest holder is Ensign Peak (Ensign Peak Advisors), with $2M, 0.0% of the portfolio.
In their latest quarter: 1 opened a new position, 2 added, 1 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Ensign Peak Ensign Peak Advisors |
New position | 431,631 | $2M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 358,738 | $2M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 159,881 | $729,057 | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 108,870 | $496,447 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 4 |
| Q1 2026 | 3 |
| Q4 2025 | 2 |
| Q3 2025 | 2 |
| Q2 2025 | 3 |
| Q1 2025 | 3 |
| Q4 2024 | 2 |
Questions about OnKure Therapeutics
Which superinvestors own OnKure Therapeutics?
4 of the superinvestors we track hold OnKure Therapeutics (OKUR) in their latest 13F filings, $5M in total. Ensign Peak, Jim Simons, Paul Marshall, Two Sigma.
Who is the largest superinvestor holder of OKUR?
The largest holder is Ensign Peak (Ensign Peak Advisors), with $2M, 0.0% of the portfolio.
From OnKure Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.